Publikationen, an denen er mitarbeitet David Hernández González (1)

2023

  1. The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 2, pp. 415-425